Clinical Trial Update: Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients [NA]

View source ↗

Summary

Clinical trial status update on Cardiac Resynchronization Therapy for previously untreatable and high-risk upgrade patients in heart failure. The sponsor is EBR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: EBR Systems, Inc. | Conditions: Heart Failure | NA | Status: ACTIVE_NOT_RECRUITING